Crestline Investors, Inc., 10% Owner at Juno Therapeutics, Inc. (JUNO), sold 8,600,000 shares at $39.00 ($335.4M) on 2016-03-01, disclosed to the SEC on 2016-03-03.
Open-market sale of $335.4M JUNO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| JUNO | SELL | 2017-07-17 | $216.0M | — | Filing → |